Minnema M, Nasserinejad K, Hazenberg B, et al. HOVON 104: results from a multicenter, prospective phase II study of bortezomib based induction treatment followed by autoogous stem cell transplantation in patients with de novo AL amyloidosis. EHA 2017, abstract S411.
Ruxolitinib bij intermediair-1 risico myelofibrose
dec 2017 | MPN, Stamceltransplantatie